It is well-known that the power of Cochran’s Q test to assess the presence of heterogeneity among treatment effects in a clinical meta-analysis is low due to t
Yin [1] has developed a new Bayesian measure of evidence for testing a point null hypothesis which agrees with the frequentist p-value thereby, solving Lindley
Fixed size without replacement sampling designs with probability functions that are linear or quadratic functions of the sampling indicators are defined and stu